Literature DB >> 6674672

Mechanisms of improvement of water and sodium excretion by immersion in decompensated cirrhotic patients.

D G Bichet, B M Groves, R W Schrier.   

Abstract

Eight patients with alcoholic liver disease, ascites, and edema were found to have impaired water (36 +/- 6% in 5 hr) and sodium (3.9 +/- 1.1 mEq/5 hr) excretion during a 20 ml/kg water load. These patients were submitted to a 5-hr head-out water immersion (HWI) with hemodynamic monitoring (Swan-Ganz). HWI increased cardiac index (3.3 to 4.2 liters/min/m2), right atrial pressure (RAP, 3.9 to 9.0 mm Hg), and wedge capillary pulmonary pressure (9.8 to 15.4 mm Hg) (all P less than 0.01). HWI decreased plasma renin activity (6.4 to 4.5 ng/ml/hr, P less than 0.001), aldosterone (73 to 43 ng/dl, P less than 0.001), arginine vasopressin (AVP, 1.03 +/- 0.15 to 0.76 +/- 0.08 pg/ml, P less than 0.005), norepinephrine (NE, 584 to 435 pg/ml, P less than 0.001) and increased the percentage of water load excreted (36 to 63%, P less than 0.005) and urinary sodium excretion (3.9 to 9.7 mEq/5 hr, P less than 0.05). The percentage of water load excreted was inversely correlated to AVP levels (r = 0.52, P less than 0.05) and directly correlated to RAP (r = 0.74, P less than 0.05). A significant positive correlation was also found between the increase in fractional excretion of sodium (delta FENa) and the increase in RAP (r = 0.77, P less than 0.001). FENa also correlated inversely with NE levels (r = 0.56, P less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6674672     DOI: 10.1038/ki.1983.229

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

1.  Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis.

Authors:  K Lenz; H Hörtnagl; W Druml; G Grimm; A Laggner; B Schneeweisz; G Kleinberger
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

2.  Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure.

Authors:  R Jalan; P C Hayes
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

3.  Role of diuretics, hormonal derangements, and clinical setting of hyponatremia in medical patients.

Authors:  P Gross; M Ketteler; C Hausmann; C Reinhard; A Schömig; E Hackenthal; E Ritz; W Rascher
Journal:  Klin Wochenschr       Date:  1988-08-01

4.  Raised urea clearance in cirrhotic patients with high uric acid clearance is related to low salt excretion.

Authors:  G Decaux; F Prospert; B Namias; M Schlesser; A Soupart
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

Review 5.  Approach and management of dysnatremias in cirrhosis.

Authors:  Mauro Bernardi; Giacomo Zaccherini
Journal:  Hepatol Int       Date:  2018-09-10       Impact factor: 6.047

Review 6.  Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?

Authors:  Hiroshi Fukui
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 7.  Management of Cirrhotic Ascites under the Add-on Administration of Tolvaptan.

Authors:  Takuya Adachi; Yasuto Takeuchi; Akinobu Takaki; Atsushi Oyama; Nozomu Wada; Hideki Onishi; Hidenori Shiraha; Hiroyuki Okada
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.